As vacinas como projecção de influência política e económica das autocracias russa e chinesa

Vaccine diplomacy boosts Russia’s and China’s global standing

In January, as many rich countries were rolling out covid-19 vaccine programmes, others were being left behind. (...) This is especially true in poor parts of the world. According to a recent tally by Agence France-Presse, a news agency, of the more than 1bn doses of vaccines that have been administered worldwide, just 0.2% have gone to people in low-income countries.

Many have turned to China and Russia for help. (...)  Such vaccine diplomacy is designed to bolster the two countries’ global standing, improve bilateral relations and gain strategic influence. (...) 

To ensure they gain a foothold in places where Western influence is declining, both China and Russia are setting up vaccine-production facilities abroad and training local workers. The two countries are playing a long game. But, besides enhancing their global prestige, they may also be using vaccines to reward loyal friends or secure particular favours. The EIU report points out that Russian officials began talks with the Bolivian government about access to mines producing rare-earth minerals and nuclear projects shortly after Russia had delivered a batch of its domestically produced Sputnik V vaccine. And China’s generosity to Cambodia and Laos may be partly explained by gratitude for their backing for China’s position on the South China Sea.

For all their diplomatic success, China and Russia have fared less well at home. China’s enormous population may stymie its own vaccination drive, and its Sinovac jab yielded an efficacy rate of just 50.7% in recent phase-three trials conducted in Brazil, barely above the 50% threshold set by the World Health Organisation for covid-19 vaccines. Meanwhile, Russia’s inoculation campaign has been sluggish because of vaccine hesitancy and production problems at home. So far both countries have administered only 0.2 shots per 100 people per day, compared with almost three times as many in Britain and France and five times as many in America. The EIU reckons that Russia will achieve widespread vaccination only in mid-2022, and China not until late that year.»